Cleveland Clinic, Siemens Healthineers expand into 10-year imaging partnership

Cleveland Clinic and Siemens Healthineers are building on a partnership that goes back more than 35 years. The two organizations signed a new 10-year deal to upgrade imaging, cardiology and radiation oncology care across the health system, giving clinical staff new tools and training while working to make the patient experience more personal, Cleveland Clinic announced in a news release.

Cleveland Clinic, a nonprofit academic medical center based in Cleveland, runs hospitals and outpatient locations across Ohio, Florida, Nevada and international sites in London, Canada and Abu Dhabi. Siemens Healthineers, a global medical technology company, has worked with Cleveland Clinic for more than 35 years, a relationship that has produced more than 100 research projects and 70 peer-reviewed publications, the companies said.

Under the deal, Siemens Healthineers will supply Cleveland Clinic with imaging and treatment equipment, including magnetic resonance imaging (MRI), computed tomography (CT), radiation oncology, interventional radiology and X-ray systems. Interventional radiology uses imaging to guide minimally invasive procedures, while radiation oncology uses targeted radiation to treat tumors.

The company will also add staff to its on-site team, which already includes more than 30 employees. Some of the new hires will help Cleveland Clinic build a theranostics cancer-treatment program, an emerging approach that often uses a radioactive drug to find and treat cancer cells, pairing targeted imaging with therapy to personalize cancer care.

Cleveland Clinic will also become a training site for Siemens Healthineers' MRI technologists, with hands-on clinical education, protocol training and radiation-safety instruction. The deal also supports plans to expand how doctors use CT scans in cardiology, radiation therapy and image-guided procedures.

The companies said the partnership could also lead to new research, training programs and software that automates parts of the imaging process. Siemens Healthineers and Cleveland Clinic are also considering biomedical engineering training programs for the Cleveland area.

“Through our longstanding relationship with Cleveland Clinic, we have achieved important advances in the diagnosis and treatment of serious disease resulting from more than 100 research projects and 70 peer-reviewed publications,” John Kowal, president and head of the Americas at Siemens Healthineers, said in the news release. “We look forward to many more years of innovation and continued positive impact on patient care.”

The deal is also expected to bring economic benefits to the region, including new jobs and investment in Cleveland Clinic's main campus, along with continued growth of the Cleveland Innovation District, a life sciences and technology hub the health system anchors with IBM and other partners.

The global theranostics market was worth $2.69 billion in 2025 and is expected to reach $7.56 billion by 2033, a compound annual growth rate of 15.4%, according to a market analysis from DataM Intelligence. That growth rate reflects how fast the market is expected to expand each year, on average, through 2033. Cleveland Clinic's move into theranostics comes as more health systems adopt the same approach to treat cancer.

“This strategic alliance with Siemens Healthineers will help us bring more consistent, connected and advanced imaging and treatment services to our patients,” Peter Liu, M.D., chair of enterprise imaging at Cleveland Clinic, said in the release. “By aligning technology, service and clinical support more closely across our global health system, we can improve access, increase efficiency and create a better experience for patients. This collaboration builds on a strong foundation and positions us to continue innovating for the benefit of our patients and communities.”